Medical Program: An Overview of RET Mutations in NSCLC

An Overview of RET Mutations in NSCLC

An Overview of RET Mutations in NSCLC
RestartResume

Up to 2 percent of lung cancer patients have a RET mutation. What kind of implications does this genetic marker have?

  • Overview

    RET mutations or rearrangements have been observed in many cancers—including non-small cell lung cancer. But what does this genetic marker mean for our patients and the treatment landscape as a whole? That’s the question Dr. Edward Kim is here to answer.

Facebook Comments

NEW FEATURES:

Register

We’re glad to see you’re enjoying Global Oncology Academy…
but how about a more personalized experience?

Register for free